✦ LIBER ✦

CV7: COST-EFFECTIVENESS OF CLOPIDOGREL IN PATIENTS WITH ISCHEMIC STROKE, MYOCARDIAL INFARCTION, OR PERIPHERAL ARTERIAL DISEASE

✍ Scribed by TE Pelea; JS Edelsberg; E Richardson; DE Singer; G Oster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV27 COST-EFFECTIVENESS ANALYSIS OF ANT

✍ BA van Hout; MJD Tangelder; P Bervoets; S Gabriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Patients With Prior Myocardial Infarctio

✍ Deepak L. Bhatt; Marcus D. Flather; Werner Hacke; Peter B. Berger; Henry R. Blac 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 534 KB

PCV30 CLOPIDOGREL IS COST-EFFECTIVE COMP

✍ MD Stevenson; AC Rawdin; JD Karnon; A Brennan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Cost of atherothrombotic diseases—myocar

✍ B. Brüggenjürgen; H.-J. Rupprecht; S. N. Willich; M. Spannagl; B. Ehlken; A. Sma 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 138 KB

ApoB/ApoA-I ratio in young patients with

✍ Adriano Paula Sabino; Marinez De Oliveira Sousa; Luciana Moreira Lima; Daniel Di 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Incidence of New Stroke or New Myocardia

✍ Gautham Ravipati; Wilbert S. Aronow; Chul Ahn; Venu Channamsetty; Vishal Sekhri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB